This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Moving Average Crossover Alert: Amerisafe
by Zacks Equity Research
Amerisafe, Inc. (AMSF) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Amerisafe Benefits from Specialty in High-Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) niche in providing workers' compensation insurance in high-hazard risk industries, coupled with balance sheet strength and appropriate enterprise risk management aids growth.
Why Is Amerisafe (AMSF) Down 0.4% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Torchmark (TMK) Poised to Grow on Strong Segmental Results
by Zacks Equity Research
Torchmark (TMK) is well positioned, given its superior performance at Global Life, Liberty National and American Income as well as strong capital management.
Aflac (AFL) Hits New 52-Week High: Is Further Upside Left?
by Zacks Equity Research
Strong operating performance in both U.S and Japan businesses is expected to continue the Aflac's (AFL) stock rally.
Amerisafe (AMSF) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Amerisafe (AMSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Amerisafe (AMSF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Amerisafe (AMSF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accident and Health Insurance Near-Term Prospects Bright
by Tanuka De
Increased underwriting exposure, sustained decrease in claims frequency rates, and conservative reserve levels should drive Accident and Health Insurance industry's performance.
Will Aflac (AFL) Retain Positive Earnings Surprise in Q1?
by Zacks Equity Research
Aflac (AFL) Q1 earnings to gain from US segment's higher contribution, partly offset by subdued results from Japan unit.
Is a Beat in the Cards for Synchrony Financial Q1 Earnings?
by Zacks Equity Research
Synchrony Financial's (SYF) first-quarter earnings are likely to grow on the back of higher purchase volume and CareCredit platform.
Can Amerisafe (AMSF) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Amerisafe (AMSF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is Amerisafe (AMSF) Down 5.9% Since Last Earnings Report?
by Zacks Equity Research
Amerisafe (AMSF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amerisafe (AMSF) Q4 Earnings Beat Estimates on Lower Expenses
by Zacks Equity Research
Amerisafe's (AMSF) Q4 earnings beat was driven by increase in net investment income and decline in total expenses.
Amerisafe (AMSF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Amerisafe (AMSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amerisafe Set to Grow on its Niche in High-Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) wide presence in high-hazard risk insurance, a strong capital position and disciplined underwriting should drive growth.
New Strong Buy Stocks for December 19th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Aflac's (AFL) Minority Stake Being Eyed by Japan Post
by Zacks Equity Research
Japan Post seems interested in buying a minority stake in Aflac (AFL) to expand its overseas business.
Near-Term Outlook for Accident and Health Insurance Industry
by Zacks Equity Research
Growth in underwriting exposure, a continued decline in claims frequency rates, and conservative reserve levels should drive Accident and Health Insurance industry's performance.
Aflac's US and Japan Business Places It Firmly for Growth
by Zacks Equity Research
Aflac's (AFL) strong U.S. segment and recovering Japan segment places it well for long-term growth.
Aflac (AFL) Launches Critical Illness Product in U.S. Unit
by Zacks Equity Research
The launch of critical illness product should boostsales in Aflac's (AFL) U.S. segment.
Top Ranked Momentum Stocks to Buy for November 6th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 6th:
Top Ranked Momentum Stocks to Buy for November 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 2nd:
Top Ranked Momentum Stocks to Buy for November 1st
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 1st:
Top Ranked Momentum Stocks to Buy for October 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 30th
Top Ranked Momentum Stocks to Buy for October 29th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 29th: